WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, April 16, 2008, 28(16):4201-4209; doi:10.1523/JNEUROSCI.0582-08.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirano, S.
Right arrow Articles by Eidelberg, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirano, S.
Right arrow Articles by Eidelberg, D.

 Previous Article  |  Next Article 

Neurobiology of Disease
Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease

Shigeki Hirano,1 Kotaro Asanuma,1,2 Yilong Ma,1,3 Chengke Tang,1 Andrew Feigin,1,3 Vijay Dhawan,1,3 Maren Carbon,1,3 and David Eidelberg1,3

1The Feinstein Institute for Medical Research, Manhasset, New York 11030, 2Department of Neurology, Tokushima University Hospital, Tokushima 770-8503, Japan, and 3Departments of Neurology and Medicine, North Shore University Hospital and New York University School of Medicine, New York, New York 10016

Correspondence should be addressed to David Eidelberg, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030. Email: david1{at}nshs.edu

We compared the metabolic and neurovascular effects of levodopa (LD) therapy for Parkinson's disease (PD). Eleven PD patients were scanned with both [15O]-H2O and [18F]-fluorodeoxyglucose positron emission tomography in the unmedicated state and during intravenous LD infusion. Images were used to quantify LD-mediated changes in the expression of motor- and cognition-related PD covariance patterns in scans of cerebral blood flow (CBF) and cerebral metabolic rate for glucose (CMR). These changes in network activity were compared with those occurring during subthalamic nucleus (STN) deep brain stimulation (DBS), and those observed in a test–retest PD control group. Separate voxel-based searches were conducted to identify individual regions with dissociated treatment-mediated changes in local cerebral blood flow and metabolism. We found a significant dissociation between CBF and CMR in the modulation of the PD motor-related network by LD treatment (p < 0.001). This dissociation was characterized by reductions in network activity in the CMR scans (p < 0.003) occurring concurrently with increases in the CBF scans (p < 0.01). Flow–metabolism dissociation was also evident at the regional level, with LD-mediated reductions in CMR and increases in CBF in the putamen/globus pallidus, dorsal midbrain/pons, STN, and ventral thalamus. CBF responses to LD in the putamen and pons were relatively greater in patients exhibiting drug-induced dyskinesia. In contrast, flow–metabolism dissociation was not present in the STN DBS treatment group or in the PD control group. These findings suggest that flow–metabolism dissociation is a distinctive feature of LD treatment. This phenomenon may be especially pronounced in patients with LD-induced dyskinesia.

Key words: Parkinson's disease; positron emission tomography; glucose metabolism; cerebral blood flow; levodopa treatment; STN DBS


Received Jan. 7, 2008; revised Feb. 27, 2008; accepted Feb. 28, 2008.

Correspondence should be addressed to David Eidelberg, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030. Email: david1{at}nshs.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. Argyelan, M. Carbon, M.-F. Ghilardi, A. Feigin, P. Mattis, C. Tang, V. Dhawan, and D. Eidelberg
Dopaminergic Suppression of Brain Deactivation Responses during Sequence Learning
J. Neurosci., October 15, 2008; 28(42): 10687 - 10695.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-